Your browser doesn't support javascript.
loading
Level of Adherence to Glaucoma Medication and Its Associated Factors Among Adult Jordanian Patients.
Alhusban, Ahmad A; Albdour, Mohannad; Alhusban, Ala A; Alhumimat, Ghadeer; Al-Qerem, Walid; Al-Bawab, Abdel Qader F.
Afiliación
  • Alhusban AA; Department of Ophthalmology, King Hussein Medical Center, Amman, JOR.
  • Albdour M; Department of Ophthalmology, King Hussein Medical Center, Amman, JOR.
  • Alhusban AA; Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, JOR.
  • Alhumimat G; Department of Ophthalmology, King Hussein Medical Center, Amman, JOR.
  • Al-Qerem W; Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, JOR.
  • Al-Bawab AQF; Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, JOR.
Cureus ; 16(6): e63475, 2024 Jun.
Article en En | MEDLINE | ID: mdl-39077272
ABSTRACT

BACKGROUND:

Glaucoma is considered the second most common cause of blindness in patients above the age of 50. Lack of adherence to glaucoma medications frequently results in undesirable complications, specifically blindness and disability.

PURPOSE:

The study's objectives are to evaluate the level of adherence to glaucoma topical medications and factors associated with adherence to glaucoma medications. PATIENTS AND

METHODS:

In total, 348 patients, of whom 48.6% were above the age of 65, were recruited. A cross-sectional study from August 2018 to March 2020 was conducted on glaucoma patients who were referred to the Department of Ophthalmology in Royal Medical Services in Amman, Jordan. A questionnaire was employed to collect patients' demographic data, level of adherence, and factors associated with medication adherence. The inclusion criteria include the following age above 20 years, diagnosis of glaucoma, currently under medical treatment, and willingness to participate in the study. Exclusion criteria include the following patients who were hospitalized for glaucoma treatment, patients who had unstable medical conditions, and any patients for whom ophthalmologists had determined that they should be excluded for any other reasons.

RESULTS:

Almost half (47.1%) of the patients adhered to their personal glaucoma medications, and the most frequent cause of nonadherence was forgetfulness (39.9%), whereas the least common was stopping the drug after feeling better (7.0%).

CONCLUSION:

Proper patient education and explanation of the seriousness of medication adherence and its association with treatment outcomes, along with assisting old and disabled patients when applying ophthalmic medications, may positively improve the adherence of patients to glaucoma and other related visual impairment medications.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos